[Federal Register Volume 87, Number 176 (Tuesday, September 13, 2022)]
[Notices]
[Pages 56089-56090]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19656]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on July 15, 2022, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise 
Consortium (``MTEC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, 1Focus LLC, Clearwater, FL; 4M Biotech, Ltd., Victoria, 
CANADA; Action Medical Technologies LLC, Conshohocken, PA; Advanced 
Biomimetic Sensors, Inc., Bethesda, MD; Aspen Stem Cell Institute LLC, 
Basalt, CO; A-Tech LLC dba BlueHalo Labs, Albuquerque, NM; Biomeme, 
Inc., Philadelphia, PA; BiotechPharma, Corp., Severna Park, MD; Bodies 
Done Right, Mayfield Village, OH; Cellphire, Inc. dba Cellphire 
Therapeutics, Inc., Rockville, MD; Collaborative Effort, Inc. dba RAIN 
Incubator, Tacoma, WA; Cornell University, Ithaca, NY; DeltaStrac LLC, 
New Windsor, MD; Eagle Global Scientific LLC, San Antonio, TX; Elephant 
Ventures LLC, New York, NY; Gateway Biotechnology, Inc., St. Louis, MO; 
HealthTech Connex, Surrey, CAN; Hememics Biotechnologies, Inc., 
Gaithersburg, MD; Human Systems Integration, Inc., East Walpole, MA; 
IDION, Inc., Darien, CT; Independent Platform LLC, Salem, OR; 
International AIDS Vaccine Initiative, New York, NY; Laulima Government 
Solutions, Orlando, FL; Link to Learn, Denver, CO; Mainstream 
Engineering Corp., Rockledge, FL; MDB, Inc., Washington, DC; MedCu 
Technologies Ltd., Herzliya, ISR; Nanobionic Technologies Limited, 
Nicosia, CYP; Neunos ZRt, Szeged, HUN; Neuro11 Technologies, Inc., 
Cambridge, MA; NeuroStat Analytical Solutions, Great Falls, VA; 
Neursantys, Inc., Chicago, IL; OARK ApS, Hammel, DNK; Omnica Corp., 
Irvine, CA; Oregon Biomedical Engineering Institute, Inc., Wilsonville, 
OR; Palantir USG, Inc., Palo Alto, CA; PathoGene, Inc., Monrovia, CA; 
Pixel and Timber LLC, Cincinnati, OH; Polaris Sensor Technologies, 
Inc., Huntsville, AL; Powerbuilding Holdings Corp., Staten Island, NY; 
Proxima Clinical Research, Houston, TX; Puerto Rico Science, Technology 
and Research Trust, San Juan, PRI; Qidni Labs, Inc., Buffalo, NY; 
Resonantia Diagnostics, New York, NY; Resusitech, Inc., Menlo Park, CA; 
Rx Bandz, Austin, TX; Senseye, Inc., Austin, TX; Shock Therapeutics 
Biotechnologies, Inc., Baltimore, MD; Siemens Medical Solutions USA, 
Inc., Princeton, NJ; Singularity Scitech LLC, Bronxville, NY; 
SmartHealth Catalyzer, Inc., Riverwoods, IL; Social Science Innovations 
Corp., New York, NY; Sonogen Medical, Inc., Chevy Chase, MD; Sonosa 
Medical, Inc., Baltimore, MD; Spectral MD, Inc., Dallas, TX; 
TensionSquare LLC, Port Charlotte, FL; Terasaki Institute for 
Biomedical Innovation, Los Angeles, CA; The Mullings Group, Delray 
Beach, FL; TMG360 Media, Delray Beach, FL; Triple Ring Technologies, 
Newark, CA; TroutHouseTech LLC, Arlington, VA; University of Alaska 
Fairbanks, Fairbanks, AK; University of Notre Dame, Notre Dame, IN; 
UTL, Inc., Carlsbad, CA; Vadum, Inc., Raleigh, NC; Virion Therapeutics 
LLC, Newark, DE; have been added as parties to this venture.
    Also, Abfero Pharmaceuticals, Inc., Boston, MA; Aerpio 
Pharmaceuticals, Cincinnati, OH; AirSupport LLC, Baltimore, MD; 
Alertgy, Inc., Melbourne, FL; Aptive Resources LLC, Alexandria, VA; 
Arteriocyte, Inc. dba Compass Biomedical, Hopkinton, MA; Ashvattha 
Therapeutics, Inc., Redwood City, CA; Asymmetric Technologies LLC, 
Columbus, OH; Bettermeant, Inc., Berkeley, CA; Boa Biomedical, Inc., 
Cambridge, MA; Board of Trustees of

[[Page 56090]]

the Leland Stanford Junior University, Palo Alto, CA; Carnegie Mellon 
University, Pittsburg, PA; Celerens LLC, Clarksville, MD; Data 
Intelligence Technologies, Inc., Arlington, VA; DataRobot, Inc., 
Boston, MA; Dawson Technical, Inc., Irvine, CA; Diagnoss, Inc., Pomona, 
CA; Diomics Corp., Murrieta, CA; DocBox, Inc., Waltham, MA; Embody LLC, 
Norfolk, VA; Evidence Based Psychology LLC dba Susan David, Newton, MA; 
FirstString Research, Inc., Mt. Pleasant, SC; Five Vital Signs, 
Houston, TX; FloTBI, Inc., Cleveland, OH; Friedman Research Corp., 
Austin, TX; Full Spectrum Omega, Inc., Los Angeles, CA; Fusion 
Consulting, Inc., Farmers Branch, TX; General Biologics, Inc., 
Cambridge, MA; Global Institute of Stem Cell Therapy and Research, 
Inc., San Diego, CA; H&H Medical Corp., Williamsburg, VA; Healing Our 
Heroes Foundation dba The Mission After, Del Mar, CA; Hybrid Plastics, 
Inc., Hattiesburg, MS; Iacta Pharmaceuticals, Inc., Irvine, CA; 
Intelligent Automation, Inc., Rockville, MD; IRegained, Inc., Sudbury, 
CAN; KMASS Solutions, El Paso, TX; Kopis Mobile LLC, Flowood, MS; L-3 
Applied Technologies, Inc., San Diego, CA; Levi Diagnostics, Inc., Fall 
River, MA; LexisNexis Risk Solutions, Inc., Washington, DC; Life365 
Inc., Scottsdale, AZ; luxML LLC, San Antonio, TX; MadApparel Ind. dba 
Athos, Redwood City, CA; ManTech Advanced Systems International, Inc., 
Herndon, VA; Medical Center of the Americas Foundation, El Paso, TX; 
Medical Informatics Corp., Houston, TX; MEDX SpA, Regi[oacute]n 
metropolitana, Santiago de Chile, CHL; Moleculin Biotech, Inc., 
Houston, TX; Movement Rx Physical Therapy, P.C., San Diego, CA; 
NanoOxygenic LLC, Dallas, TX; NeurAegis, Inc., Southborough, MA; 
Neuronasal, Inc., Wexford, PA; Nexsys Electronics Inc. dba Medweb, San 
Francisco, CA; Nostromo LLC, Kennebunk, ME; Novel Technologies Holdings 
Limited, Manchester, NH; Noveome Biotherapeutics, Inc., Pittsburg, PA; 
Obatala Sciences, Inc., New Orleans, LA; Odin Technologies, Charlotte, 
NC; OLGS, Inc., Imperial, PA; Oregon Health & Science University, 
Portland, OR; Osteal Therapeutics, Inc., San Clemente, CA; Overseas 
Strategic Consulting, Ltd, Philadelphia, PA; Oxygenium, Inc., Great 
Neck, NY; Panakeia LLC, Newport News, VA; PercuSense, Inc., Valencia, 
CA; Platelet BioGenesis, Inc., Cambridge, MA; Presidio Government 
Solutions LLC, Reston, VA; Programs Management Analytics & 
Technologies, Inc., Norfolk, VA; Q30 Sports Science LLC, Westport, CT; 
QuesGen Systems, Burlingame, CA; Renaissance Biotech LLC, Malibu, CA; 
Resolys Bio, Inc., Delanson, NY; ServiceNow, Inc., Vienna, VA; 
SpherIngenics, Inc., Richmond, VA; StataDX, Inc., Cambridge, MA; 
Synthesis Technologies, Inc., Pasadena, CA; Tanner Research, Inc., 
Duarte, CA; TeleCommunication Systems, Inc., Annapolis, MD; Through The 
Cords LLC, Salt Lake City, UT; Traumatic Direct Transfusion Devices 
LLC, Raleigh, NC; Tunnell Consulting, Inc., Bethesda, MD; University of 
Connecticut, Storrs, CT; University of Kansas Medical Center Research 
Institute, Inc., Kansas City, KS; ViiNetwork, Inc ViiMed, Washington, 
DC; Wearable Artificial Organs, Inc., Beverly Hills, CA; WearOptimo, 
Woolloongabba, Queensland, AUS; Western Michigan University Homer 
Stryker M.D. School of Medicine, Kalamazoo, MI; XSurgical, Inc., 
Ipswich, MA; Zansors LLC, Arlington, VA; have withdrawn as parties to 
this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on April 14, 
2022. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on May 13, 2022 (87 FR 29382).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2022-19656 Filed 9-12-22; 8:45 am]
BILLING CODE P